LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 3 of 166
Next
>>
>
51 to 75 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Relative Growth Rate After Treatment
BT-20	GSK1059615	0.04	uM	LJP6	72	hr	1097	3105	3769	0.8237	0.7513
BT-20	GSK1904529A	0.04	uM	LJP6	72	hr	1097	3113	3769	0.8260	0.7546
BT-20	Omipalisib	0.04	uM	LJP6	72	hr	1097	778	3769	0.2064	-0.1195
BT-20	GSK 690693	0.04	uM	LJP5	72	hr	1097	3239	3769	0.8593	0.8016
BT-20	GW843682X	0.04	uM	LJP6	72	hr	1097	3006	3769	0.7976	0.7145
BT-20	HG-5-113-01	0.04	uM	LJP5	72	hr	1097	3850	3769	1.0215	1.0304
BT-20	HG-5-88-01	0.04	uM	LJP6	72	hr	1097	2905	3769	0.7707	0.6765
BT-20	Imatinib	0.04	uM	LJP6	72	hr	1097	3748	3769	0.9944	0.9921
BT-20	JNK-9L	0.04	uM	LJP6	72	hr	1097	2987	3769	0.7926	0.7074
BT-20	JW-7-24-1	0.04	uM	LJP6	72	hr	1097	2963	3769	0.7862	0.6984
BT-20	Lapatinib	0.04	uM	LJP6	72	hr	1097	2916	3769	0.7736	0.6806
BT-20	LDN-193189	0.04	uM	LJP5	72	hr	1097	3807	3769	1.0099	1.0140
BT-20	Linifanib	0.04	uM	LJP6	72	hr	1097	3950	3769	1.0481	1.0678
BT-20	Linsitinib	0.04	uM	LJP5	72	hr	1097	3436	3769	0.9116	0.8753
BT-20	Mitoxantrone	0.04	uM	LJP5	72	hr	1097	1459	3769	0.3872	0.1356
BT-20	Mitoxantrone	0.04	uM	LJP6	72	hr	1097	1404	3769	0.3725	0.1148
BT-20	MK2206	0.04	uM	LJP6	72	hr	1097	3292	3769	0.8734	0.8214
BT-20	Neratinib	0.04	uM	LJP5	72	hr	1097	2893	3769	0.7676	0.6721
BT-20	Nilotinib	0.04	uM	LJP5	72	hr	1097	3963	3769	1.0515	1.0726
BT-20	Nintedanib	0.04	uM	LJP6	72	hr	1097	3560	3769	0.9444	0.9216
BT-20	NU7441	0.04	uM	LJP5	72	hr	1097	4119	3769	1.0929	1.1310
BT-20	Dactolisib	0.04	uM	LJP5	72	hr	1097	1392	3769	0.3693	0.1103
BT-20	NVP-TAE684	0.04	uM	LJP6	72	hr	1097	3786	3769	1.0045	1.0064
BT-20	Palbociclib	0.04	uM	LJP6	72	hr	1097	2420	3769	0.6421	0.4951
BT-20	Afatinib	0.04	uM	LJP6	72	hr	1097	2874	3769	0.7625	0.6650

|<
<<
Previous
Page 3 of 166
Next
>>
>
51 to 75 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)